Navigating Uncertainty in Adjuvant Mitotane Therapy

Affiliations

¹ Internal Medicine 1, Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy. Electronic address: terzolo@usa.net.
² Division of Endocrinology and Diabetes, Department of Medicine, University Hospital of Würzburg, Würzburg, Germany.
³ Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
⁴ Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.

Massimo Terzolo et al. Endocr Pract. 2025 Jul.

. 2025 Jul;31(7):975-976.

doi: 10.1016/j.eprac.2025.03.012. Epub 2025 Mar 31.

¹ Internal Medicine 1, Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy. Electronic address: terzolo@usa.net.
² Division of Endocrinology and Diabetes, Department of Medicine, University Hospital of Würzburg, Würzburg, Germany.
³ Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
⁴ Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.

No abstract available

Conflict of interest statement

Disclosure The authors have no conflicts of interest to disclose.